Medical Technology Company Announces Commercial Major Expansion

T2 Biosystems, Inc. (NASDAQ:TTOO), a prominent name in the rapid detection of sepsis-causing pathogens and antibiotic-resistant genes, recently announced a major step in its commercial expansion strategy. The company has executed a territory-exclusive distribution agreement encompassing Malaysia and Indonesia. This strategic decision will see the distribution of the T2Dx® Instrument, the T2Bacteria® Panel, the T2Candida® Panel, and the T2Resistance® Panel through a newly appointed distributor in these regions. $T2 Biosystems (TTOO.US)$